Relationship of calcitonin mRNA expression to the differentiation state of HL 60 cells.
Raised plasma levels of immunoreactive human calcitonin (ihCT) can be found in patients with myeloid leukemia and seem to indicate a poor prognosis. High levels were found in acute undifferentiated and acute myeloblastic leukemia. To test whether CT expression could be a marker of myeloid differentiation, we used the promyelocytic leukemia cell line HL 60 which also expresses ihCT as a model system for myeloid differentiation. Exponentially growing HL 60 cells as well as differentiation induced HL 60 cells expressed a single 1.0 Kb CT transcript. The induction of HL 60 cell differentiation along the granulocytic lineage by DMSO or HMBA had no effect on the level of CT transcripts. Induction of monocytic/macrophagic differentiation by TPA resulted in a transient, about 10-fold elevated expression of CT steady state mRNA after 24 h. In contrast to TPA, induction of HL 60 cell differentiation along the monocytic pathway by Vit D3 had no detectable effect on the level of the CT in RNA expression at corresponding time points. These findings suggest that the transient induction of CT steady state mRNA expression by TPA is rather a direct effect of the phorbol ester than commitment along the monocytic line of differentiation.
Kiefer
P
P
Philipps-University Marburg, Department of Internal Medicine, Germany.
Bacher
M
M
Pflüger
K H
KH
D000081:Acetamides / Q000494:pharmacology; D002116:Calcitonin / Q000235:genetics*; D015740:Calcitonin Gene-Related Peptide / Q000235:genetics; D002454:Cell Differentiation / Q000187:drug effects / Q000502:physiology; D002455:Cell Division / Q000502:physiology; D002762:Cholecalciferol / Q000494:pharmacology; D004121:Dimethyl Sulfoxide / Q000494:pharmacology; D015870:Gene Expression; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000235:genetics* / Q000473:pathology*; D008264:Macrophages / Q000187:drug effects / Q000473:pathology; D008954:Models, Biological; D009000:Monocytes / Q000187:drug effects / Q000473:pathology; D010641:Phenotype; D012333:RNA, Messenger / Q000235:genetics*; D013194:Staining and Labeling / Q000379:methods; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014407:Tumor Cells, Cultured / Q000187:drug effects
D000081:Acetamides; D012333:RNA, Messenger; D002762:Cholecalciferol; D002116:Calcitonin; D015740:Calcitonin Gene-Related Peptide; C014026:hexamethylene bisacetamide; D013755:Tetradecanoylphorbol Acetate; D004121:Dimethyl Sulfoxide